Expert Opinions - Prioritising Primary Prevention | Daiichi Sankyo UK Cardio Health

Home
Resources and support
Why should primary prevention lipid management be prioritised?

Why should primary prevention lipid management be prioritised?

In this video, Laura Cox detailed why primary prevention lipid management should be a key focus for UK HCPs to reduce patients’ CVD risk

Laura Cox

Date: 01/02/2026

3 mins

Speaker bios

Laura Cox

Pharmacist Western Health and Social Care Trust, Belfast

Role of bempedoic acid in the management of CV risk reduction in type 2 diabetes and elevated LDL-C and real-world experience Previous The role of bempedoic acid in the management of CV risk reduction in primary prevention lipid management Next

Abbreviations

CV, cardiovascular; CVD, cardiovascular disease; HCP, healthcare professional; UK, United Kingdom.

Job code: UK/BIL/01/26/0001|Date of preparation: June 2026

You are now leaving this website

Please note that our terms of use (especially those mentioned under "Terms and Conditions") are no longer valid as soon as you click on the "Continue" button. As we do not have any influence on linked websites, we assume no liability for their content or use. If you would like to return to our website, please click the "Return" button.

This is a Daiichi Sankyo site intended for UK healthcare professionals (HCPs) and other relevant decision makers,* where you can find promotional information about Daiichi Sankyo products and professional resources.

So that we can provide you with the most appropriate information, please choose one of the following options:

I am a UK healthcare professional

This website contains promotional information intended for UK healthcare professionals and other relevant decision makers only.

Confirm

I am a member of the public

This website provides members of the UK public with details about Daiichi Sankyo and its medicines. For further information about your health or medicines please consult your doctor, nurse or pharmacist.

Confirm

*Other relevant decision makers particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply, or use of any medicine but who are not healthcare professionals.